rs116823205

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_018060.4(IARS2):​c.111G>C​(p.Thr37Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 1,612,858 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 13 hom., cov: 32)
Exomes 𝑓: 0.010 ( 98 hom. )

Consequence

IARS2
NM_018060.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.877

Publications

2 publications found
Variant links:
Genes affected
IARS2 (HGNC:29685): (isoleucyl-tRNA synthetase 2, mitochondrial) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of isoleucine-tRNA synthetase exist, a cytoplasmic form and a mitochondrial form. This gene encodes the mitochondrial isoleucine-tRNA synthetase which belongs to the class-I aminoacyl-tRNA synthetase family. [provided by RefSeq, Dec 2014]
BPNT1 (HGNC:1096): (3'(2'), 5'-bisphosphate nucleotidase 1) BPNT1, also called bisphosphate 3-prime-nucleotidase, or BPntase, is a member of a magnesium-dependent phosphomonoesterase family. Lithium, a major drug used to treat manic depression, acts as an uncompetitive inhibitor of BPntase. The predicted human protein is 92% identical to mouse BPntase. BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The inhibition of human BPntase may account for lithium-induced nephrotoxicity. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 1-220094327-G-C is Benign according to our data. Variant chr1-220094327-G-C is described in ClinVar as Benign. ClinVar VariationId is 381167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.877 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00884 (1347/152314) while in subpopulation NFE AF = 0.0123 (838/68004). AF 95% confidence interval is 0.0116. There are 13 homozygotes in GnomAd4. There are 637 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018060.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IARS2
NM_018060.4
MANE Select
c.111G>Cp.Thr37Thr
synonymous
Exon 1 of 23NP_060530.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IARS2
ENST00000366922.3
TSL:1 MANE Select
c.111G>Cp.Thr37Thr
synonymous
Exon 1 of 23ENSP00000355889.2Q9NSE4
IARS2
ENST00000930953.1
c.111G>Cp.Thr37Thr
synonymous
Exon 1 of 23ENSP00000601012.1
IARS2
ENST00000948321.1
c.111G>Cp.Thr37Thr
synonymous
Exon 1 of 23ENSP00000618380.1

Frequencies

GnomAD3 genomes
AF:
0.00884
AC:
1346
AN:
152196
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00227
Gnomad AMI
AF:
0.0504
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0122
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.0123
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.00892
AC:
2140
AN:
239802
AF XY:
0.00899
show subpopulations
Gnomad AFR exome
AF:
0.00180
Gnomad AMR exome
AF:
0.00812
Gnomad ASJ exome
AF:
0.0149
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00952
Gnomad NFE exome
AF:
0.0131
Gnomad OTH exome
AF:
0.0145
GnomAD4 exome
AF:
0.0103
AC:
15057
AN:
1460544
Hom.:
98
Cov.:
32
AF XY:
0.0101
AC XY:
7304
AN XY:
726596
show subpopulations
African (AFR)
AF:
0.00180
AC:
60
AN:
33402
American (AMR)
AF:
0.00862
AC:
385
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.0159
AC:
416
AN:
26092
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39656
South Asian (SAS)
AF:
0.000754
AC:
65
AN:
86216
European-Finnish (FIN)
AF:
0.00913
AC:
483
AN:
52882
Middle Eastern (MID)
AF:
0.00711
AC:
41
AN:
5766
European-Non Finnish (NFE)
AF:
0.0118
AC:
13080
AN:
1111552
Other (OTH)
AF:
0.00872
AC:
526
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
837
1674
2511
3348
4185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
486
972
1458
1944
2430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00884
AC:
1347
AN:
152314
Hom.:
13
Cov.:
32
AF XY:
0.00855
AC XY:
637
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00226
AC:
94
AN:
41582
American (AMR)
AF:
0.0106
AC:
163
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
54
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.0122
AC:
130
AN:
10624
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.0123
AC:
838
AN:
68004
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
65
130
195
260
325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
5
Bravo
AF:
0.00862
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0124
EpiControl
AF:
0.0141

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
IARS2-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
2.3
DANN
Benign
0.65
PhyloP100
-0.88
PromoterAI
-0.063
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116823205; hg19: chr1-220267669; API